Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Fast Melt Tablets Market from 2024 to 2025?

The market for fast melt tablets has seen impressive growth over the past few years. The market value is anticipated to grow from $4.96 billion in 2024 to $5.38 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.4%. The significant expansion during the historic period owes much to the growing elderly population, an upsurge in chronic diseases, an inclination towards self-medication, the widening scope of the pharmaceutical industry, and a rise in disposable income.

What Is the Projected Market Size of the Fast Melt Tablets Market?

In the following years, there is projected to be substantial growth in the fast melt tablets market, anticipated to reach $7.35 billion by 2029, at an 8.1% compound annual growth rate (CAGR). The anticipated escalation throughout this forecast period is attributable to factors such as the increasing incidence of dysphagia, the preference trend for over-the-counter medications, expanding online market penetration, a surge in demand for orally dissolving medications, and improved health care infrastructure. Key trends predicted to shape this forecast period include technological breakthroughs, fresh formulation methods, the introduction of nanotechnology, a shift towards botanical excipients, and advanced drug delivery systems.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Who are the Major Competitors in the Fast Melt Tablets Market Outlook?

Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

What Is Fueling Growth in the Fast Melt Tablets Market?

The escalation in heart attack occurrences is anticipated to fuel the expansion of the fast melt tablets market in the future. Heart attacks represent a medical crisis resulting from the blockage of blood circulation to the heart muscle, usually caused by a blood clot or the accumulation of plaque in the coronary arteries. The surge in heart attack incidents attributes largely to the increased intake of processed foods leading to elevated cholesterol and arterial plaque accumulation. Fast melt tablets offer a swiftly absorbing drug solution that facilitates quicker delivery of vital drugs such as aspirin or nitroglycerin, minimizing further damage in the event of a heart attack and enhancing patient results through the restoration of blood circulation and decreased risk of major complications. For instance, as per the British Heart Foundation, a cardiovascular research charity in the UK, it was reported that over 39,000 premature deaths in England occurred in 2022 due to cardiovascular issues like heart attacks, coronary heart disease, and stroke – averaging 750 deaths weekly. These numbers represent the highest ever recorded. Thus, the upward trend in heart attacks promotes the growth of the fast melt tablets market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

Which Fast Melt Tablets Market Segments Are Growing the Fastest?

The fast melt tablets market covered in this report is segmented –

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types

2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications

3) By Dosage Form: Oral, Sublingual, Buccal, Chewable

4) By Age Group: Adult, Pediatrics, Geriatrics

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics

2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors

3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives

4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines

5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics

6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics

7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors

8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids

9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole

10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

Which Industry Trends Are Shaping the Future of the Fast Melt Tablets Market?

Major firms in the fast melt tablets market are concentrating their efforts on creating innovative products like rapidly dissolving tablets for improved patient comfort and quicker medication absorption. Rapidly dissolving tablets (RDTs) are a type of solid dosage that is designed to dissolve fast in the mouth without requiring water. For example, Melt Pharmaceuticals, a clinical-stage pharmaceutical company based in the United States, introduced Melt 300, a state-of-the-art fast-melting tablet formulation designed specifically for efficient sedation, in December 2022. Composed of midazolam (3 mg) and ketamine (50 mg), this ground-breaking sublingual fast-melting tablet dissolves instantly, guaranteeing a quick onset and efficient sedation without the necessity for intravenous administration. By offering a needle-free, patient-friendly sedation alternative, Melt 300 is catering to the increasing demand and simultaneously improving procedural comfort and optimizing clinical processes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

Which Countries Are Leading the Fast Melt Tablets Market?

North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23398

This Report Delivers Insight On:

1. How big is the fast melt tablets market, and how is it changing globally?

2. Who are the major companies in the fast melt tablets market, and how are they performing?

3. What are the key opportunities and risks in the fast melt tablets market right now?

4. Which products or customer segments are growing the most in the fast melt tablets market?

5. What factors are helping or slowing down the growth of the fast melt tablets market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model